Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Infectious & Toxicology
Filter     Order     Display # 
Date Item Title
17 Jul 2008 Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
15 Jul 2008 Rib-X Pharmaceuticals, Inc. Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
10 Jul 2008 BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
08 Jul 2008 Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
08 Jul 2008 Giaconda Limited Suspends Hepaconda Phase II Trial to Carry Out Dose Ranging
08 Jul 2008 Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
30 Jun 2008 Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
30 Jun 2008 Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
30 Jun 2008 Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
29 Jun 2008 iCo Therapeutics Reports New iCo-009 (Oral Amphotericin B) Preclinical Results
29 Jun 2008 Optimer Reports Additional Data on Investigational Compound OPT-80 at Anaerobe 2008 Congress
26 Jun 2008 European approval for Roche's Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment
26 Jun 2008 SciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study
25 Jun 2008 Medicago's H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal Model
25 Jun 2008 Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
25 Jun 2008 Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients
19 Jun 2008 Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
17 Jun 2008 CSL Receives TGA Approval to Register Panvax(R), Avian Flu Vaccine
16 Jun 2008 GlaxoSmithKline and Mpex Pharmaceuticals form alliance to develop novel efflux pump inhibitors for use against serious gram-negative infections
16 Jun 2008 Vical Pandemic Influenza Vaccines Provide Complete Protection in Animal Studies; The Journal of Infectious Diseases Publishes H5N1 Challenge Data
15 Jun 2008 Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
15 Jun 2008 Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Psudomonas Lung Infections
12 Jun 2008 Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
12 Jun 2008 Phase III data show GSK paediatric candidate vaccine’s potential to provide improved protection against life-threatening pneumococcal diseases
12 Jun 2008 OPKO Acquires Rights to Novel Phase II Agent to Treat Viral Conjunctivitis
12 Jun 2008 Promising Data Presented on Genvec Malaria Vaccine Program
10 Jun 2008 Symphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
10 Jun 2008 Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine
10 Jun 2008 Targanta submits marketing authorization application for Oritavancin
08 Jun 2008 Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
05 Jun 2008 Pacgen Announces Positive Results from Phase IIb Dose-Ranging Trial of PAC-113
04 Jun 2008 NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
04 Jun 2008 Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study
04 Jun 2008 Novartis presents full pipeline of novel vaccines addressing significant unmet needs
03 Jun 2008 Hemispherx Biopharma Press Release for
03 Jun 2008 Novartis gains rights to promising hospital antibiotic in clinical development through full acquisition of Protez Pharmaceuticals
30 May 2008 VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data
29 May 2008 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
29 May 2008 ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
29 May 2008 InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
29 May 2008 Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
28 May 2008 Santaris Pharma begins human clinical testing of the world’s first medicine targeted at a human microRNA
28 May 2008 4SC and ViroLogik conclude a licensing and cooperation agreement
28 May 2008 Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine
28 May 2008 Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvnated Seasonal Influenza Vaccine
27 May 2008 Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
26 May 2008 Arpida enrols first patients in "intravenous-to-oral" switch trial with oral iclaprim
22 May 2008 Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
21 May 2008 Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
20 May 2008 Ceftobiprole shows high cure rates in patients hospitalized with community-acquired pneumonia
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 151 - 200 of 1267

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics